Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 6, 2013, Pages 2288-2293

  Schubert, Undine ^a   Schmid, Janine ^a   Lehmann, Susann ^a   Zhang, Xian Y ^b,c,d   Morawietz, Henning ^a   Block, Norman L ^b,c,d   Kanczkowski, Waldemar ^a   Schally, Andrew V ^b,c,d   Bornstein, Stefan R ^a,e   Ludwig, Barbara ^a,e  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d South Florida Veterans Affairs Foundation for Research and Education   (United States)

^e GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Cell replacement; Regenerative therapy; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; MR 403; UNCLASSIFIED DRUG;

ADRENAL CELL; ADRENAL GLAND; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG POTENCY; ENGRAFTMENT; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INSULINOMA; KIDNEY CAPSULE; MICROENVIRONMENT; MOUSE; NONHUMAN; OXYGEN TENSION; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADRENAL GLANDS; ANIMALS; CELL LINE; COCULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RNA, MESSENGER; TRANSPLANTATION CONDITIONING;

EID: 84873455727     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1221505110     Document Type: Article

References (42)

1. Gerstein HC, et al.; ACCORD Study Group (2011) Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 364(9):818-828.
2. Polak JF, et al.; DCCT/EDIC Research Group (2011) Progression of carotid artery intimamedia thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes 60(2):607-613.
3. CITR Research Group (2009) 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR). Cell Transplant 18(7):753-767.
4. Barton FB, et al. (2012) Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35(7):1436-1445.
5. Shapiro AM, et al. (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355(13):1318-1330.
6. Thompson DM, et al. (2011) Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 91(3):373-378.
7. Ludwig B, Ludwig S, Steffen A, Saeger HD, Bornstein SR (2010) Islet versus pancreas transplantation in type 1 diabetes: Competitive or complementary? Curr Diab Rep 10 (6):506-511.
8. Paraskevas S, Maysinger D, Wang R, Duguid TP, Rosenberg L (2000) Cell loss in isolated human islets occurs by apoptosis. Pancreas 20(3):270-276.
9. Goto M, et al. (2005) Key factors for human islet isolation and clinical transplantation. Transplant Proc 37(2):1315-1316.
10. Lakey JR, Burridge PW, Shapiro AM (2003) Technical aspects of islet preparation and transplantation. Transpl Int 16(9):613-632.
11. Carlsson PO, Palm F, Andersson A, Liss P (2001) Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50(3): 489-495.
12. Lehmann R, et al. (2007) Superiority of small islets in human islet transplantation. Diabetes 56(3):594-603.
13. Bennet W, et al. (1999) Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 48(10):1907-1914.
14. Espes D, Eriksson O, Lau J, Carlsson PO (2011) Striated muscle as implantation site for transplanted pancreatic islets. J Transplant 2011:352043.
15. Jindal RM, Sidner RA, McDaniel HB, Johnson MS, Fineberg SE (1998) Intraportal vs kidney subcapsular site for human pancreatic islet transplantation. Transplant Proc 30(2):398-399.
16. Kim JS, et al. (2012) In situ application of hydrogel-type fibrinislet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. J Control Release 162(2):382-390.
17. Coppens V, et al. (2012) Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes. Diabetologia 56(2):382-390.
18. Kakabadze Z, et al. (2012) An isolated venous sac as a novel site for cell therapy in diabetes mellitus. Transplantation 94(4):319-324.
19. Arias-Díaz J, et al. (1996) CT-guided fine-needle approach for intrathymic islet transplantation in a diabetic patient. Pancreas 12(1):100-102.
20. Nasr IW, et al. (2005) Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J Immunol 174(10): 6161-6168.
21. Barkai U, et al. (2012) Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant, in press.
22. Buchwald P, et al. (2010) Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation. Pharmazie 65(6):421-428.
23. Gibly RF, Zhang X, Lowe WL, Shea LD (2012) Porous scaffolds support extrahepatic human islet transplantation, engraftment and function in mice. Cell Transplant, in press.
24. Ludwig B, et al. (2012) Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci USA 109(13):5022-5027.
25. Pedraza E, et al. (2012) Macroporous three dimensional PDMS scaffolds for extrahepatic islet transplantation. Cell Transplant, in press.
26. Armann B, Hanson MS, Hatch E, Steffen A, Fernandez LA (2007) Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant 7(1):38-47.
27. Bottino R, et al. (2004) Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 53(10):2559-2568.
28. Emamaullee JA, et al. (2008) The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes 57(6):1556-1566.
29. Mysore TB, et al. (2005) Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes 54(7):2109-2116.
30. Ansurudeen I, et al. (2006) Vascular-adrenal niche: Endothelial cell-mediated sensitization of human adrenocortical cells to angiotensin II. Horm Metab Res 38(7): 476-480.
31. Albertin G, et al. (2005) Adrenomedullin and vascular endothelium growth factor genes are overexpressed in the regenerating rat adrenal cortex, and AM and VEGF reciprocally enhance their mRNA expression in cultured rat adrenocortical cells. Int J Mol Med 16(3):431-435.
32. Hinson JP, Kapas S (1998) The role of endothelial cell products in the regulation of adrenocortical function: Actions of endothelin, nitric oxide, adrenomedullin and PAMP. Horm Metab Res 30(6-7):334-340.
33. Powers JW, Mazilu JK, Lin S, McCabe ER (2010) The effects of hyperglycemia on adrenal cortex function and steroidogenesis in the zebrafish. Mol Genet Metab 101(4): 421-422.
34. Mazilu JK, Powers JW, Lin S, McCabe ER (2010) ff1b, the SF1 ortholog, is important for pancreatic islet cell development in zebrafish. Mol Genet Metab 101(4):391-394.
35. Morales A, et al. (2008) Differential expression of steroidogenic factors 1 and 2, cytochrome p450scc, and steroidogenic acute regulatory protein in human pancreas. Pancreas 37(2):165-169.
36. Izdebski J, et al. (1995) Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA 92(11):4872-4876.
37. Ludwig B, et al. (2010) Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci USA 107(28):12623-12628.
38. Kanashiro-Takeuchi RM, et al. (2012) Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci USA 109(2):559-563.
39. Kanashiro-Takeuchi RM, et al. (2010) Cardioprotective effects of growth hormonereleasing hormone agonist after myocardial infarction. Proc Natl Acad Sci USA 107(6): 2604-2609.
40. Chavakis T, Kanczkowski W, Willenberg HS, Bornstein SR (2011) Endothelial dysfunction: A critical determinant in inflammation-associated adrenal insufficiency? Eur J Clin Invest 41(8):917-919.
41. Cardoso CC, Bornstein SR, Hornsby PJ (2010) Optimizing orthotopic cell transplantation in the mouse adrenal gland. Cell Transplant 19(5):565-572.
42. Schmid J, et al. (2011) Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proc Natl Acad Sci USA 108(33):13722-13727.